Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Calvo

Showing results (101-110 of 127) with videos related to

Pageof 13
Sort By:
Journal of Crohn'S & Colitis|March 26, 2026
Influence of vedolizumab on extraintestinal manifestations in inflammatory bowel disease: a nationwide multicenter study of the GETECCU ENEIDA RegistryPablo Pérez-Galindo, Javier P Gisbert, Marta Carrillo-Palau, et al.
Alimentary Pharmacology & Therapeutics|August 21, 2019
Increased risk of thiopurine-related adverse events in elderly patients with IBDMargalida Calafat, Míriam Mañosa, Fiorella Cañete, et al.
Gastroenterologia Y Hepatologia|September 12, 2008
Open-label infliximab therapy in Crohn's disease: a long-term multicenter study of efficacy, safety and predictors of responseYago González-Lama, Antonio López-San Román, Ignacio Marín-Jiménez, et al.
Journal of Crohn'S & Colitis|October 12, 2019
Interstitial and Granulomatous Lung Disease in Inflammatory Bowel Disease PatientsElena Eliadou, Joana Moleiro, Davide Giuseppe Ribaldone, et al.
Hepatology (Baltimore, Md.)|April 8, 2022
Beneficial effect of ursodeoxycholic acid in patients with acyl-CoA oxidase 2 (ACOX2) deficiency-associated hypertransaminasemiaMarta Alonso-Peña, Ricardo Espinosa-Escudero, Elisa Herraez, et al.
European Journal of Human Genetics : EJHG|January 8, 2026
Domain-specific phenotypic profiles in RAF1-related Noonan syndromeAndrea Gazzin, Marta Calvo, Federico Rondot, et al.
Journal of Medical Internet Research|August 27, 2024
Telemonitoring of Active Inflammatory Bowel Disease Using the App TECCU: Short-Term Results of a Multicenter Trial of GETECCUMariam Aguas, Javier Del Hoyo, Raquel Vicente, et al.
Gastroenterologia Y Hepatologia|January 13, 2024
Position statement of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis on sexuality and inflammatory bowel diseaseMarta Calvo Moya, Francisco Mesonero Gismero, Cristina Suarez Ferrer, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 26, 2026
The TECCU-based telemonitoring platform for Inflammatory Bowel Disease is Cost-Effective: A Multicenter GETECCU TrialMariam Aguas, Javier Del Hoyo, Raquel Vicente, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 10, 2022
Ustekinumab and vedolizumab for the prevention of postoperative recurrence of Crohn's disease: Results from the ENEIDA registryMíriam Mañosa, Agnès Fernández-Clotet, Pilar Nos, et al.
Pageof 13

Showing results (101-110 of 127) with videos related to

Sort By:
Pageof 13
Journal of Crohn'S & Colitis|March 26, 2026
Influence of vedolizumab on extraintestinal manifestations in inflammatory bowel disease: a nationwide multicenter study of the GETECCU ENEIDA RegistryPablo Pérez-Galindo, Javier P Gisbert, Marta Carrillo-Palau, et al.
Alimentary Pharmacology & Therapeutics|August 21, 2019
Increased risk of thiopurine-related adverse events in elderly patients with IBDMargalida Calafat, Míriam Mañosa, Fiorella Cañete, et al.
Gastroenterologia Y Hepatologia|September 12, 2008
Open-label infliximab therapy in Crohn's disease: a long-term multicenter study of efficacy, safety and predictors of responseYago González-Lama, Antonio López-San Román, Ignacio Marín-Jiménez, et al.
Journal of Crohn'S & Colitis|October 12, 2019
Interstitial and Granulomatous Lung Disease in Inflammatory Bowel Disease PatientsElena Eliadou, Joana Moleiro, Davide Giuseppe Ribaldone, et al.
Hepatology (Baltimore, Md.)|April 8, 2022
Beneficial effect of ursodeoxycholic acid in patients with acyl-CoA oxidase 2 (ACOX2) deficiency-associated hypertransaminasemiaMarta Alonso-Peña, Ricardo Espinosa-Escudero, Elisa Herraez, et al.
European Journal of Human Genetics : EJHG|January 8, 2026
Domain-specific phenotypic profiles in RAF1-related Noonan syndromeAndrea Gazzin, Marta Calvo, Federico Rondot, et al.
Journal of Medical Internet Research|August 27, 2024
Telemonitoring of Active Inflammatory Bowel Disease Using the App TECCU: Short-Term Results of a Multicenter Trial of GETECCUMariam Aguas, Javier Del Hoyo, Raquel Vicente, et al.
Gastroenterologia Y Hepatologia|January 13, 2024
Position statement of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis on sexuality and inflammatory bowel diseaseMarta Calvo Moya, Francisco Mesonero Gismero, Cristina Suarez Ferrer, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 26, 2026
The TECCU-based telemonitoring platform for Inflammatory Bowel Disease is Cost-Effective: A Multicenter GETECCU TrialMariam Aguas, Javier Del Hoyo, Raquel Vicente, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 10, 2022
Ustekinumab and vedolizumab for the prevention of postoperative recurrence of Crohn's disease: Results from the ENEIDA registryMíriam Mañosa, Agnès Fernández-Clotet, Pilar Nos, et al.
Pageof 13